Tissue Genesis
We focus on clinical validation of the use of a patient’s own adipose- (fat) derived stem cells, referred to as the Stromal Vascular Fraction (SVF), to treat conditions such as heart disease, vascular disease, orthopedic and spine injury, soft tissue and reconstructive repair, and pelvic health disorders among many others. Founded on the premise of improving the quality of life for patients and their families, that has remained a guiding principle as we continue to grow. Tissue Genesis is the FIRST company to conduct an FDA-approved clinical trial for cell therapy using adipose-derived stem cells isolated at the point-of-care with an automated system. http://www.tissuegenesis.com/ |